Home › Vision Impairment and Blindness › California
Vision Impairment and Blindness clinical trials in California
4 studies for Vision Impairment and Blindness are looking for participants at sites in California.
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
- Byers Eye Institute at Stanford University, Palo Alto
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT05844982Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
- UCSF Wayne and Gladys Valley Center for Vision, San Francisco
RecruitingPhase 3
Ages 6 and older · All sexes · Updated Oct 21, 2026 · NCT06891443OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
- Global Research Management, Glendale
- Gordon Schanzlin New Vision, La Jolla
- Eye Research Foundation, Newport Beach
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07140783Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- University of California San Francisco, San Francisco
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Mar 11, 2026 · NCT02521311From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.